Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zachary Z. Reinstein"'
Autor:
Lijie Zhai, Bin Zhang, Charles David James, Craig Horbinski, Derek A. Wainwright, Priya Kumthekar, Kaitlyn O'Shea, Maciej M. Mrugala, Zachary Z. Reinstein, Lifang Hou, Karan Dixit, Andreas Mozny, Masha Kocherginsky, Kristen L. Lauing, Maya Hrachova, April Bell, Bakhtiar Yamini, Rimas V. Lukas, David A. Reardon, Erik Rabin, Erik Ladomersky, Margaret Johnson, Lakshmi Reddy Bollu, Yinan Zheng, Vikram C. Prabhu, Quinn T. Ostrom, Leonidas C. Platanias, Miri Kim, Jennifer D. Wu, Sarah A. Merrill
Publikováno v:
Neuro-oncology Advances
Background Advanced age is a major risk factor for the development of many diseases including those affecting the central nervous system. Wild-type isocitrate dehydrogenase glioblastoma (IDHwt GBM) is the most common primary malignant brain cancer an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ade28136e1e155071a627f2a3c5e728
https://doi.org/10.1093/noajnl/vdab125
https://doi.org/10.1093/noajnl/vdab125
Autor:
Francis J. Giles, Sarki A. Abdulkadir, Vinay Sagar, Benedito A. Carneiro, Ricardo Costa, Zachary Z. Reinstein, Sahithi Pamarthy
Publikováno v:
Critical Reviews in Oncology/Hematology. 117:114-127
Bone metastases are present in up to 70% of advanced prostate and breast cancers and occur at significant rates in a variety of other cancers. Bone metastases can be associated with significant morbidity. The establishment of bone metastasis activate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78914e1f49b88fc2737bb40f1ddcf590
https://doi.org/10.1016/j.critrevonc.2017.05.004
https://doi.org/10.1016/j.critrevonc.2017.05.004
Autor:
Evita G. Weagel, Eliza L. Lawrence, Zachary Z. Reinstein, John E. Lattin, Kim L. O'Neill, Richard A. Robison, Roger Chu, Lu Liu, Kiara V. Whitley, Scott Weber, Michelle H. Townsend, Taylor D. Brindley, Brandon T. Garcia, Edwin J. Velazquez
Publikováno v:
Cancer Research. 78:2563-2563
Recent clinical trials using chimeric antigen receptors (CAR) T cells have demonstrated tremendous success in eradicating hematologic malignancies. Notwithstanding the excitement generated by CAR T cell therapy, its clinical efficacy has not been eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4d2b25b64f9add8b669997b87c40d56
https://doi.org/10.1158/1538-7445.am2018-2563
https://doi.org/10.1158/1538-7445.am2018-2563
Autor:
Jonathan F. Anker, Sarki A. Abdulkadir, Zachary Z. Reinstein, Sahithi Pamarthy, Benedito A. Carneiro, Rajita Vatapalli
Publikováno v:
Cancer Research. 77:1230-1230
Prostate cancer is the most common cancer among men, other than skin cancer, in the United States. When the cancer enters into the metastatic castration resistant stage (mCRPC), few treatment options are currently available and the disease is conside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c7b5de94c6e8faa57939632179b7045
https://doi.org/10.1158/1538-7445.am2017-1230
https://doi.org/10.1158/1538-7445.am2017-1230
Autor:
Sahithi Pamarthy, Benedito A. Carneiro Filho, Sarki A. Abdulkadir, Zachary Z. Reinstein, Rajita Vatapalli, Muhammad Zayd Ansari, Vinay Sagar, Francis J. Giles
Publikováno v:
Cancer Research. 77:1114-1114
Androgen deprivation therapy is an efficient first line therapy for advanced prostate cancer. However, in most cases resistance inevitably develops resulting in metastatic castration-resistant prostate cancer (mCRPC). Abiraterone and enzalutamide are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d67c7601136130fec2c9536aa8da41f7
https://doi.org/10.1158/1538-7445.am2017-1114
https://doi.org/10.1158/1538-7445.am2017-1114